These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 27459907
1. Coix seed emulsion synergistically enhances the antitumor activity of gemcitabine in pancreatic cancer through abrogation of NF-κB signaling. Qian Y, Yang B, Xiong Y, Gu M. Oncol Rep; 2016 Sep; 36(3):1517-25. PubMed ID: 27459907 [Abstract] [Full Text] [Related]
2. Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by 6-shogaol. Zhou L, Qi L, Jiang L, Zhou P, Ma J, Xu X, Li P. AAPS J; 2014 Mar; 16(2):246-57. PubMed ID: 24424498 [Abstract] [Full Text] [Related]
3. Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo. Wang YW, Wang SJ, Zhou YN, Pan SH, Sun B. J Cancer Res Clin Oncol; 2012 May; 138(5):785-97. PubMed ID: 22270965 [Abstract] [Full Text] [Related]
6. Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma. Chen D, Niu M, Jiao X, Zhang K, Liang J, Zhang D. Int J Mol Sci; 2012 May; 13(1):1186-1208. PubMed ID: 22312312 [Abstract] [Full Text] [Related]
7. [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine]. Liu A, Hu YS, Wang ZH, Tang LL, Ke PY, Lin SZ. Yao Xue Xue Bao; 2011 Feb; 46(2):146-52. PubMed ID: 21542284 [Abstract] [Full Text] [Related]
9. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo. Wang ZH, Chen H, Guo HC, Tong HF, Liu JX, Wei WT, Tan W, Ni ZL, Liu HB, Lin SZ. Int J Oncol; 2011 Nov; 39(5):1123-31. PubMed ID: 21743963 [Abstract] [Full Text] [Related]
11. Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer. Mu GG, Zhang LL, Li HY, Liao Y, Yu HG. Dig Dis Sci; 2015 Apr; 60(4):1067-80. PubMed ID: 25344906 [Abstract] [Full Text] [Related]
12. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, Philip PA, Abbruzzese J, Sarkar FH. Cancer Res; 2005 Oct 01; 65(19):9064-72. PubMed ID: 16204081 [Abstract] [Full Text] [Related]
14. [An experimental study of gemcitabine inducing pancreatic cancer cell apoptosis potentiated by nuclear factor-kappa B P65 siRNA]. Kong R, Sun B, Wang SJ, Pan SH, Wang G, Chen H, Xue DB, Jiang HC. Zhonghua Wai Ke Za Zhi; 2010 Jan 15; 48(2):128-33. PubMed ID: 20302733 [Abstract] [Full Text] [Related]
18. Coix Seed Extract Enhances the Anti-Pancreatic Cancer Efficacy of Gemcitabine through Regulating ABCB1- and ABCG2-Mediated Drug Efflux: A Bioluminescent Pharmacokinetic and Pharmacodynamic Study. Qian Y, Xiong Y, Feng D, Wu Y, Zhang X, Chen L, Gu M. Int J Mol Sci; 2019 Oct 23; 20(21):. PubMed ID: 31652737 [Abstract] [Full Text] [Related]
19. Shikonin suppresses tumor growth and synergizes with gemcitabine in a pancreatic cancer xenograft model: Involvement of NF-κB signaling pathway. Wang Y, Zhou Y, Jia G, Han B, Liu J, Teng Y, Lv J, Song Z, Li Y, Ji L, Pan S, Jiang H, Sun B. Biochem Pharmacol; 2014 Apr 01; 88(3):322-33. PubMed ID: 24522113 [Abstract] [Full Text] [Related]
20. Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation. Ju HQ, Li H, Tian T, Lu YX, Bai L, Chen LZ, Sheng H, Mo HY, Zeng JB, Deng W, Chiao PJ, Xu RH. J Pineal Res; 2016 Jan 01; 60(1):27-38. PubMed ID: 26445000 [Abstract] [Full Text] [Related] Page: [Next] [New Search]